Recombinant DNA Advisory Committee - 
I. CALL TO ORDER AND INTRODUCTORY REMARKS: 
Dr. McGarrity, Chair, called the meeting of the Recombinant DNA Advisory Committee 
(RAC) of the National Institutes of Health (NIH) to order at 9:00 a.m., February 4, 
1991. The meeting was called pursuant to a Federal Renter notice which, being 30 or 
more days prior to today's date, met requirements of the NIH Guidelines for Research 
Involving Recombinant DNA Molecules. The meeting would remain open to the public 
for its entirety, and that he expected the meeting to conclude within one day. 
Dr. McGarrity noted a quorum was present and said every attempt would be made not 
to limit debate, but to keep the agenda moving, in hopes that all agenda items could be 
heard and discussed before members had to leave for travel purposes. 
Dr. McGarrity stated that the RAC was advisory to the Director of NIH and that any 
action taken by the committee was not binding on the NIH, but that Director may 
choose to accept, reject, modify, or defer any recommendations or advice provided by the 
RAC. 
Dr. McGarrity noted that he intended to make every effort to abide by the distributed 
agenda with respect to time estimates for each item of business. He reminded the 
committee that in recognizing persons for comments he would use the following order: 
primary and secondary reviewers on each item as set forth in the agenda; other members 
of RAC; ad hoc consultants to the RAC; NIH staff members; members of the public who 
had submitted written comments; and finally, other members of the public. 
Dr. McGarrity then called on Dr. Post to report on the next agenda item. 
II. MINUTES OF OCTOBER 16, 1990 MEETING: ^ 
Dr. Post said the minutes were consistent with his recollection of the meeting with the 
exception of the fourth paragraph on page 13 of the minutes which deals with the 
modification to Appendix K of the NIH Guidelines. His recollection was that this agenda 
item was not voted on, but was turned back over to the subcommittee for further review. 
Dr. McGarrity said this was his recollection as well and asked the staff of the Office of 
Recombinant DNA Activities (ORDA) to ensure that the language in the minutes was 
consistent with the official transcript of the meeting. 
Dr. McGarrity noted that the secondary reviewer was supposed to be Dr. Acosta, who 
had announced her resignation from the RAC due to increased job responsibilities in a 
new institution. Her resignation would be accepted with regrets and that Dr. McGarrity 
had written Dr. Acosta a letter thanking her for her service. In the absence of a 
secondary reviewer. Dr. McGarrity read the minutes and found a few housekeeping items 
[450] 
Recombinant DNA Research, Volume 14 
